Zoe Billinghurst/ LinkedIn
Jun 14, 2026, 15:51
Zoe Billinghurst: Strengthening the Global Rare Blood Disorders Community at EHA 2026
Zoe Billinghurst, Senior Global Brand Director of Rare Blood and Renal Disorders at Novo Nordisk, shared post on LinkedIn:
“Building insights about Rare Blood Disorders – global unmet needs, clinical practice, research advances – steps forward since EHA 2025.
Building on established collaborations and instigating new ones. Amazing and intense week in Stockholm at EHA 2026 with amazing colleagues from Novo Nordisk Rare Disease team.”
Stay updated with Hemostasis Today.
-
Sep 22, 2026, 19:02Blocking Histone-Induced Platelet-Erythrocyte Interactions With Polyanions – Platelets Journal
-
Sep 22, 2026, 18:49Abdul Rahman Hamad: Early Action for Better Outcomes in Deep Vein Thrombosis
-
Sep 22, 2026, 18:37Carmine Siniscalchi: Age-Adjusted D-Dimer Cutoffs in DVT Diagnosis
-
Sep 22, 2026, 18:37Stefano Romeo: The Cardiovascular Patient Journey is Still Full of Gaps
-
Sep 22, 2026, 18:11Bharath Kumar V.։ Advancing Safer Anticoagulation for Cancer-Associated Thrombosis
-
Sep 22, 2026, 18:10Fatima Zahra: ASH Released New Guidelines on the Diagnosis of Iron Deficiency
-
Sep 22, 2026, 17:49Nirav Dhanesha: Targeting FXI for Safer Anticoagulation
-
Sep 22, 2026, 17:17Eric Lambert: Intravascular Imaging and the Future of Precision PCI
-
Sep 22, 2026, 16:45Claudiu Stoicescu: Are We Starting Cardiovascular Risk Assessment Too Late?